Published in J Clin Invest on June 01, 1994
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med (2004) 18.86
Cellular mechanisms of insulin resistance. J Clin Invest (2000) 12.61
Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science (2003) 11.39
Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest (1999) 6.73
Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev (2007) 6.53
Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest (1996) 6.50
The metabolic syndrome. Endocr Rev (2008) 5.33
Lipid-induced insulin resistance: unravelling the mechanism. Lancet (2010) 4.88
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest (2005) 4.81
Etiology of insulin resistance. Am J Med (2006) 4.44
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest (2001) 3.64
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest (1999) 3.18
Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest (2003) 3.11
Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol (2003) 2.95
Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med (2005) 2.72
Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes (2008) 2.71
Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci U S A (2008) 2.71
Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes (2011) 2.67
Obesity and free fatty acids. Endocrinol Metab Clin North Am (2008) 2.64
Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest (1994) 2.51
Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes (2011) 2.43
Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest (2006) 2.40
Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest (2002) 2.30
Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest (2004) 1.83
Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest (1998) 1.82
Pancreatic function, type 2 diabetes, and metabolism in aging. Int J Endocrinol (2012) 1.77
Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. J Clin Invest (2003) 1.73
Skeletal muscle fat oxidation: timing and flexibility are everything. J Clin Invest (2005) 1.72
Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice. Proc Natl Acad Sci U S A (2008) 1.68
Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes (2009) 1.67
Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab (2011) 1.64
Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest (1996) 1.60
Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest (2005) 1.55
Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest (1997) 1.49
Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest (1995) 1.47
Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children. Crit Care Med (2010) 1.46
Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes (2010) 1.41
Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. J Clin Invest (1997) 1.37
Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity (Silver Spring) (2009) 1.37
Toward a unifying hypothesis of metabolic syndrome. Pediatrics (2012) 1.36
Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice. J Clin Invest (2005) 1.35
Intramuscular lipid metabolism, insulin action, and obesity. IUBMB Life (2009) 1.33
Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metabolism (2008) 1.32
Nonoxidative free fatty acid disposal is greater in young women than men. J Clin Endocrinol Metab (2010) 1.31
Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J Clin Invest (1996) 1.29
Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) (2008) 1.27
Alternatives for macronutrient intake and chronic disease: a comparison of the OmniHeart diets with popular diets and with dietary recommendations. Am J Clin Nutr (2008) 1.23
Reversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: a mechanism integrating glycolytic flux with lipid metabolism. J Biol Chem (2011) 1.18
Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci U S A (2014) 1.15
Activation of SIRT1 by resveratrol represses transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) by deacetylating hepatic nuclear factor 4alpha. J Biol Chem (2009) 1.12
Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling. Diabetes (2011) 1.10
Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest (1998) 1.09
Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice. Exp Mol Med (2009) 1.08
Metabolic actions of insulin in men and women. Nutrition (2010) 1.07
A prospective study of prepregnancy dietary fat intake and risk of gestational diabetes. Am J Clin Nutr (2012) 1.04
Fat-specific protein 27 (FSP27) interacts with adipose triglyceride lipase (ATGL) to regulate lipolysis and insulin sensitivity in human adipocytes. J Biol Chem (2014) 1.04
Symposium introduction: metabolic syndrome and the onset of cancer. Am J Clin Nutr (2007) 1.04
Macrophage CGI-58 deficiency activates ROS-inflammasome pathway to promote insulin resistance in mice. Cell Rep (2014) 0.99
Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Physiol Endocrinol Metab (2010) 0.99
Role of adipose specific lipid droplet proteins in maintaining whole body energy homeostasis. Biochim Biophys Acta (2013) 0.99
Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models. Br J Pharmacol (2003) 0.99
A role for aberrant protein palmitoylation in FFA-induced ER stress and β-cell death. Am J Physiol Endocrinol Metab (2012) 0.98
Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis. J Biol Chem (2012) 0.98
Solution structure of human intestinal fatty acid binding protein: implications for ligand entry and exit. J Biomol NMR (1997) 0.97
Triglyceride-rich lipoprotein-associated apolipoprotein C-III production is stimulated by plasma free fatty acids in humans. Arterioscler Thromb Vasc Biol (2008) 0.95
Metabolic effects of low glycaemic index diets. Nutr J (2009) 0.95
Free fatty acid-induced PP2A hyperactivity selectively impairs hepatic insulin action on glucose metabolism. PLoS One (2011) 0.94
A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1. PLoS One (2013) 0.93
Evidence for reverse flux through pyruvate kinase in skeletal muscle. Am J Physiol Endocrinol Metab (2009) 0.93
Aging per se increases the susceptibility to free fatty acid-induced insulin resistance. J Gerontol A Biol Sci Med Sci (2010) 0.93
Insulin resistance, metabolic stress, and atherosclerosis. Front Biosci (Schol Ed) (2012) 0.93
The Macrophage Switch in Obesity Development. Front Immunol (2016) 0.93
Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord (2015) 0.92
Plasma triglycerides are not related to tissue lipids and insulin sensitivity in elderly following PPAR-alpha agonist treatment. Mech Ageing Dev (2007) 0.92
Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus. PLoS One (2013) 0.92
Adipose tissue dysfunction in humans: a potential role for the transmembrane protein ENPP1. J Clin Endocrinol Metab (2012) 0.92
Measurement of the increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Methods Enzymol (2011) 0.90
Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals. Am J Physiol Endocrinol Metab (2011) 0.90
Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol Ther (2008) 0.89
Insulin resistance in adolescents with Down syndrome: a cross-sectional study. BMC Endocr Disord (2005) 0.88
A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma. Diabetes (2011) 0.88
The pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol (N Y) (2007) 0.87
Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective. Heart Fail Rev (2002) 0.87
Palmitate action to inhibit glycogen synthase and stimulate protein phosphatase 2A increases with risk factors for type 2 diabetes. Am J Physiol Endocrinol Metab (2007) 0.87
Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment. J Lipid Res (2016) 0.87
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care (2015) 0.86
Low muscle glycogen and elevated plasma free fatty acid modify but do not prevent exercise-induced PDH activation in human skeletal muscle. Diabetes (2009) 0.86
Trans-resveratrol attenuates high fatty acid-induced P2X7 receptor expression and IL-6 release in PC12 cells: possible role of P38 MAPK pathway. Inflammation (2015) 0.86
Peripheral adipose tissue insulin resistance alters lipid composition and function of hippocampal synapses. J Neurochem (2015) 0.86
Insulin sensitivity is related to fat oxidation and protein kinase C activity in children with acute burn injury. J Burn Care Res (2008) 0.85
Computational model of cellular metabolic dynamics: effect of insulin on glucose disposal in human skeletal muscle. Am J Physiol Endocrinol Metab (2010) 0.85
Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes. J Clin Endocrinol Metab (2009) 0.84
Altered subcutaneous abdominal adipose tissue lipid synthesis in obese, insulin-resistant humans. Am J Physiol Endocrinol Metab (2013) 0.84
Distinct metabolic effects following short-term exposure of different high-fat diets in male and female mice. Endocr J (2014) 0.83
Twenty-eight-day bed rest with hypercortisolemia induces peripheral insulin resistance and increases intramuscular triglycerides. Metabolism (2009) 0.83
Role of transcription factor modifications in the pathogenesis of insulin resistance. Exp Diabetes Res (2011) 0.82
Role of lipotoxicity in endothelial dysfunction. Heart Fail Clin (2012) 0.82
Stevioside Counteracts Beta-Cell Lipotoxicity without Affecting Acetyl CoA Carboxylase. Rev Diabet Stud (2007) 0.81
The rs340874 PROX1 type 2 diabetes mellitus risk variant is associated with visceral fat accumulation and alterations in postprandial glucose and lipid metabolism. Genes Nutr (2015) 0.81
Vascular effects of intravenous intralipid and dextrose infusions in obese subjects. Metabolism (2012) 0.80
The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes (1981) 7.28
Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med (1990) 7.13
Pathogenesis of NIDDM. A balanced overview. Diabetes Care (1992) 6.56
A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem (1968) 6.22
What if Minkowski had been ageusic? An alternative angle on diabetes. Science (1992) 6.07
Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes (1965) 5.42
Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol (1956) 5.26
Effect of fatty acids on glucose production and utilization in man. J Clin Invest (1983) 4.00
AUTOMATED AND MANUAL DIRECT METHODS FOR THE DETERMINATION OF BLOOD UREA. Clin Chem (1965) 3.74
Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes (1988) 3.67
Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med (1989) 3.38
Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci U S A (1966) 2.76
Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest (1993) 2.68
Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest (1990) 2.50
The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann N Y Acad Sci (1965) 2.26
GLYCOGEN SYNTHETASE ACTIVITY IN SKELETAL MUSCLE. INTERCONVERSION OF TWO FORMS AND CONTROL OF GLYCOGEN SYNTHESIS. J Biol Chem (1965) 2.00
Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.96
Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism (1982) 1.79
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism (1987) 1.76
Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest (1990) 1.67
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes (1992) 1.60
Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J Clin Invest (1990) 1.55
Effect of elevated free fatty acids on glucose oxidation in normal humans. Metabolism (1988) 1.52
Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1991) 1.49
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest (1993) 1.35
Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest (1989) 1.34
Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes (1986) 1.31
Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest (1991) 1.31
Glycogen synthase activation in human skeletal muscle: effects of diet and exercise. Am J Physiol (1979) 1.30
Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes (1990) 1.20
Carbohydrate oxidation and storage in obese non-insulin-dependent diabetic patients. Effects of improving glycemic control. Diabetes (1983) 1.18
Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest (1991) 1.16
Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol (1993) 1.15
Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes (1988) 1.14
Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol (1990) 1.08
Mechanism of palmityl coenzyme A inhibition of liver glycogen synthase. J Biol Chem (1977) 1.07
Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Evidence for an abnormality specific to glucose metabolism. Diabetes (1993) 1.03
Skeletal muscle is a major site of lactate uptake and release during hyperinsulinemia. Metabolism (1992) 1.03
Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis. Diabetes (1980) 1.02
Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol (1993) 0.99
Multiple metabolic effects of CGRP in conscious rats: role of glycogen synthase and phosphorylase. Am J Physiol (1993) 0.98
Effects of intensive dietary treatment on insulin-stimulated skeletal muscle glycogen synthase activation and insulin secretion in newly presenting type 2 diabetic patients. Diabet Med (1990) 0.95
In vivo and in vitro effects of antiinsulin receptor antibodies. J Clin Endocrinol Metab (1984) 0.95
Palmitate stimulates glucose transport in rat adipocytes by a mechanism involving translocation of the insulin sensitive glucose transporter (GLUT4). Biochem Biophys Res Commun (1991) 0.94
Mechanisms limiting glycogen storage in muscle during prolonged insulin stimulation. Am J Physiol (1988) 0.94
Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes (1991) 0.94
Effects of oleate and fatty acids from omental adipocytes on insulin uptake in rat liver cells. Endocrinology (1993) 0.84
TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res (2000) 15.70
The TRANSFAC system on gene expression regulation. Nucleic Acids Res (2001) 13.63
ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell (2000) 9.13
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. Nucleic Acids Res (1999) 6.70
A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58
Natural engineering principles of electron tunnelling in biological oxidation-reduction. Nature (1999) 6.38
Revealing the maximum strength in nanotwinned copper. Science (2009) 6.27
Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol (1998) 5.54
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci U S A (1996) 4.76
Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea. Lancet (1991) 4.52
A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol (1996) 4.47
Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest (1987) 4.26
Cdc25 cell-cycle phosphatase as a target of c-myc. Nature (1996) 4.23
Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17
Development of microsatellite markers and characterization of simple sequence length polymorphism (SSLP) in rice (Oryza sativa L.). Mol Gen Genet (1996) 3.75
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest (2001) 3.64
CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med (2000) 3.62
Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol (1998) 3.61
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A (2003) 3.53
Functionalized graphene sheets for polymer nanocomposites. Nat Nanotechnol (2008) 3.45
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A (2000) 3.36
SVM-Prot: Web-based support vector machine software for functional classification of a protein from its primary sequence. Nucleic Acids Res (2003) 3.34
Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol (1994) 3.32
Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol (2008) 3.25
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J (1996) 3.22
Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell (2001) 3.10
Evolutionarily conserved sequences on human chromosome 21. Genome Res (2001) 2.95
Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int (2007) 2.92
Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother (1996) 2.91
Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob Agents Chemother (1994) 2.87
Central melanocortin receptors regulate insulin action. J Clin Invest (2001) 2.83
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest (1992) 2.80
An information-based sequence distance and its application to whole mitochondrial genome phylogeny. Bioinformatics (2001) 2.80
Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res (2000) 2.79
Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab (2001) 2.79
Filamentous growth of Candida albicans in response to physical environmental cues and its regulation by the unique CZF1 gene. Mol Microbiol (1999) 2.74
The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the beta 2-adrenergic receptor. J Biol Chem (2000) 2.67
A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature (1998) 2.66
Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest (1991) 2.65
Perceived discrimination and early substance abuse among American Indian children. J Health Soc Behav (2001) 2.60
Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60
Mesoscale vertical motion and the size structure of phytoplankton in the ocean. Nature (2001) 2.60
Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem (1999) 2.57
A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev (1993) 2.53
The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci (2004) 2.47
Agrobacterium-Mediated Transformation of Fusarium oxysporum: An Efficient Tool for Insertional Mutagenesis and Gene Transfer. Phytopathology (2001) 2.43
An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature (1997) 2.42
p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene (2001) 2.40
English language use as a risk factor for smoking initiation among Hispanic and Asian American adolescents: evidence for mediation by tobacco-related beliefs and social norms. Health Psychol (2000) 2.36
Structure of the trp RNA-binding attenuation protein, TRAP, bound to RNA. Nature (1999) 2.35
Effect of grapefruit juice on blood cyclosporin concentration. Lancet (1995) 2.33
Overfeeding rapidly induces leptin and insulin resistance. Diabetes (2001) 2.32
A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry (2007) 2.30
Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes (1999) 2.25
ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease. Antimicrob Agents Chemother (1998) 2.23
NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene (2011) 2.22
Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (1995) 2.19
Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes. Diabetologia (2001) 2.18
Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med (1998) 2.17
The role of social networks and media receptivity in predicting age of smoking initiation: a proportional hazards model of risk and protective factors. Addict Behav (1999) 2.14
Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci U S A (1999) 2.14
The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc Natl Acad Sci U S A (1993) 2.11
Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol (1999) 2.11
Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab (1996) 2.10
Tic20 and Tic22 are new components of the protein import apparatus at the chloroplast inner envelope membrane. J Cell Biol (1998) 2.08
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med (1995) 2.08
Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nat Med (2001) 2.08
A gene expression screen in zebrafish embryogenesis. Genome Res (2001) 2.08
Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. Am J Hum Genet (1995) 2.07
The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res (1998) 2.06
Detection of antigen-antibody binding events with the atomic force microscope. Biochemistry (1997) 2.05
Salmonella enterica serovar virchow with CTX-M-like beta-lactamase in Spain. J Clin Microbiol (2000) 2.04
PharmGED: pharmacogenetic effect database. Clin Pharmacol Ther (2007) 2.02
Intestinal-enriched Krüppel-like factor (Krüppel-like factor 5) is a positive regulator of cellular proliferation. J Biol Chem (2001) 2.01
Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett (2008) 2.01
Severe diffuse non-scarring hair loss in systemic lupus erythematosus - clinical and histopathological analysis of four cases. J Eur Acad Dermatol Venereol (2011) 1.99
Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother (1997) 1.97
Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology (1993) 1.95
Prevalence of Staphylococcus aureus carrying Panton-Valentine leukocidin genes among isolates from hospitalised patients in China. Clin Microbiol Infect (2008) 1.95
Interactions within the yeast t-SNARE Sso1p that control SNARE complex assembly. Nat Struct Biol (2000) 1.94
Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J (1999) 1.93
Deletion analysis of K+ channel assembly. Neuron (1993) 1.91
[Minimal intervention in smoking in the outpatient pneumonology consultation]. Arch Bronconeumol (1994) 1.91
Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest (1998) 1.90
Structural analysis based on state-space modeling. Protein Sci (1993) 1.89
Use of whole genome sequence data to infer baculovirus phylogeny. J Virol (2001) 1.89
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med (1995) 1.88
Measurement of the rate of nu(e) + d --> p + p + e(-) interactions produced by (8)B solar neutrinos at the Sudbury Neutrino Observatory. Phys Rev Lett (2001) 1.88
Evidence for a circadian rhythm of insulin secretion. Am J Physiol (1996) 1.86
Inhibition of FEN-1 processing by DNA secondary structure at trinucleotide repeats. Mol Cell (1999) 1.83
Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut (2000) 1.82
Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest (1998) 1.82
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.82
Idiopathic stabbing headache (jabs and jolts syndrome) Cephalalgia (1996) 1.82
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet (2001) 1.80
Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem (1998) 1.80
Identification of a novel p53 functional domain that is necessary for mediating apoptosis. J Biol Chem (1998) 1.80